Letter: Questions on antenatal screening for Down's syndrome
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: Your article on antenatal screening, and specifically the 'triple test' for Down's syndrome, highlighted the concern over 'false positive' results. Here in East Sussex, where we offer the 'triple test' to all mothers, the laboratory carrying out the tests has an excellent 'false positive' rate for Down's syndrome - just 2.9 per cent of the total tests.
All mothers are informed of the test and may refuse it if they wish - around 65 per cent accept. Although anxiety is increased if the result is 'screen positive', we do our best to ensure that this is kept to a minimum. Results are given face-to-face by the midwife and an appointment is made to discuss the result with a consultant the following day; amniocentesis is available at the same time if required.
The question is whether it is worth making so many women anxious for the sake of detecting one affected pregnancy. Our figures show that for every mother who has to make a decision about whether to continue her Down's syndrome-affected pregnancy, 21 other mothers are made unnecessarily anxious by a 'screen positive' result that is subsequently found to be normal. We try to minimise this anxiety, but the decision to be screened in the first place means there is a price to pay for choice. For younger women, this is a choice they were previously denied.
Yours faithfully,
MARY PIGGOTT
Triple Test Co-ordinator
Department of
Chemical Pathology
East Sussex Health Authority
Brighton, East Sussex
26 January
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments